“Two-phase”的搜索结果，显示 31-40 项，共有 4327 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

4. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   ... two future steps: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken with Q901 at the RP2D administered in combination with pembrolizumab (400 mg Q6W) ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a Phase 2 global, multi-center, open-label study to assess the ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and ...

10. 外科 - 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...